161581-93-7 Usage
Uses
Used in Pharmaceutical Research:
4-BROMO-3-FLUORO-4'-METHOXYBENZOPHENONE is used as a potential anticancer agent for its ability to induce apoptosis in cancer cells. Its unique structure and potential therapeutic benefits make it a significant compound in the field of pharmaceutical research.
Used in Cancer Treatment:
4-BROMO-3-FLUORO-4'-METHOXYBENZOPHENONE is used as a selective anticancer agent, particularly in the treatment of solid tumors. Its ability to induce apoptosis in cancer cells makes it a promising candidate for cancer therapy.
Used in Drug Development:
4-BROMO-3-FLUORO-4'-METHOXYBENZOPHENONE is used in the development of new drugs for cancer treatment. Its highly reactive and potentially cytotoxic properties make it a valuable compound for the creation of novel therapeutic agents.
Used in Cancer Research:
4-BROMO-3-FLUORO-4'-METHOXYBENZOPHENONE is used as a research tool to study the mechanisms of apoptosis induction in cancer cells. Understanding its effects on cancer cells can help in the development of more effective cancer treatments.
Check Digit Verification of cas no
The CAS Registry Mumber 161581-93-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,1,5,8 and 1 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 161581-93:
(8*1)+(7*6)+(6*1)+(5*5)+(4*8)+(3*1)+(2*9)+(1*3)=137
137 % 10 = 7
So 161581-93-7 is a valid CAS Registry Number.
InChI:InChI=1/C14H10BrFO2/c1-18-13-7-4-10(8-12(13)16)14(17)9-2-5-11(15)6-3-9/h2-8H,1H3
161581-93-7Relevant articles and documents
CHEMICAL COMPOUNDS
-
Page/Page column 80-81, (2008/06/13)
The present invention relates to novel compounds with a variety of therapeutic uses, more particularly novel substituted cyclic alkylidene compounds that are particularly useful for selective estrogen receptor modulation.
Amino alkenyloxybenzene derivatives
-
, (2008/06/13)
A method of lowering cholesterol which comprises administering to a host requiring such treatment an effective amount of a compound of the formula STR1 wherein one of R1 and R2 is C1-7 -alkyl and the other is C1-7 -alkyl or C2-6 -alkenyl-methyl; L is C1-11 -alkylene or C2-11 -alkenylene optionally bonded to the phenyl group via an O atom or L is 1,4-phenylene; n is 0 or, when L contains an O atom, n is 0 or 1; Q is C1-7 -alkyl, C2-10 -alkenyl or a group of formula STR2 wherein R is H, halogen, CF3, CN or NO2 ; R3 and R4 are H, C1-4 -alkyl or halogen; and R5 is H or, when R is H, R5 is H or halogen; or a pharmaceutically acceptable acid addition salt thereof, as well as certain compounds of formula I, are described.